Rini Noviyani et al. 2023. COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE. Journal Pharmaceutical Science and Application. 5, 1 (Jun. 2023), 34–44. DOI:https://doi.org/10.24843/JPSA.2023.v05.i01.p05.